Maclar 500 Tablet contains Clarithromycin 500 mg, a macrolide antibiotic effective against a broad spectrum of bacterial infections. It functions by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and replication. Maclar 500 is commonly prescribed for the treatment of respiratory tract infections, including community-acquired pneumonia, acute exacerbations of chronic bronchitis, sinusitis, and pharyngitis/tonsillitis. Additionally, it is indicated for skin and soft tissue infections, as well as Helicobacter pylori eradication in combination with other agents for the treatment of peptic ulcer disease. The tablet should be administered orally, with or without food, as directed by a healthcare professional. Dosage and duration of therapy depend on the type and severity of infection. Clarithromycin is generally well tolerated; however, potential side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Rarely, it may cause hepatic dysfunction, hypersensitivity reactions, or QT interval prolongation. Caution is advised in patients with hepatic or renal impairment, and drug interactions should be carefully monitored due to Clarithromycin’s inhibition of cytochrome P450 enzymes. Maclar 500 Tablet should be used under medical supervision to ensure appropriate use and to minimize the risk of antibiotic resistance.